Industry:
Drug Manufacturing,
Pharmaceuticals,
Biotechnology
InterMune, Inc., is a biopharmaceutical company focused on developing and commercializing innovative therapies in hepatology and pulmonology. We market Actimmune® (interferon gamma-1b), approved for the treatment of severe, malignant osteopetrosis and chronic granulomatous disease. We have a late-stage and preclinical development pipeline in the areas of pulmonology and hepatology. In pulmonology, we are developing two therapies for the treatment of idiopathic pulmonary fibrosis (IPF): interferon gamma-1b and pirfenidone. In hepatology, we are focused on expanding treatment options for patients suffering from HCV
Contact with InterMune , Inc.:
3280 Bayshore Blvd
Brisbane,
California
94005
USA
Tel: (415) 466-2200
Fax: (415) 466-2300
Web Site: www.intermune.com
Instant Messenger:
N/A